A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia; Myocardial infarction
- Focus Therapeutic Use
- Acronyms DIAPAsOn
- Sponsors Abbott Laboratories
- 03 Jul 2019 Status changed from active, no longer recruiting to completed.
- 01 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2018 Status changed from not yet recruiting to recruiting.